Oklahoma City, OKNCT05712395Now EnrollingIRB Ready

Claudication Clinical Trial in Oklahoma City, OK

Access cutting-edge claudication treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.

Sponsored by University of Oklahoma

Quick Self-Assessment

See if you qualify for this Oklahoma City location

Preparing your pre-screening questions…

Expert Care in Oklahoma City

Access claudication specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related claudication treatment provided free

Apply for This Oklahoma City Location

Check if you qualify for this claudication clinical trial in Oklahoma City, OK

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Oklahoma City

    Convenient for OK residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Oklahoma City site if eligible
  4. 4Begin participation

About This Claudication Study in Oklahoma City

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the Non-Ischemic Exercise (NICE) program to improve exercise and vascular outcome measures in patients with peripheral artery disease (PAD).

Sponsor: University of Oklahoma

Who Can Participate

Inclusion Criteria

history of claudication assessed by the Walking Impairment Questionnaire,
ambulatory leg pain in either one or both legs consistent with intermittent claudication confirmed during a screening graded treadmill test using the Gardner-Skinner protocol,
an ABI \<= 0.90 at rest or \> 20% decrease in ankle systolic blood pressure in either one or both legs immediately following the treadmill exercise test.
age \>= 40 years.

Exclusion Criteria

absence of PAD (ABI \> 0.90 at rest and ankle systolic blood pressure \< 20% decrease after exercise,
inability to obtain an ABI measure due to non-compressible vessels (ABI \> 1.40),
asymptomatic PAD (Fontaine Stage I) determined from the medical history and verified during the graded treadmill test,
rest pain due to PAD (Fontaine stage III)
tissue loss due to PAD (Fontaine stage IV)
use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation,
peripheral revascularization within one month prior to investigation, or peripheral revascularization performed during the study,
exercise tolerance limited by any disease process other than PAD,
active cancer,
kidney failure defined as stage 5 chronic kidney disease,
a calf skin fold measurement \> 25 mm, because of potential interference with the light path of the NIRS probe from penetrating the subcutaneous tissue,
pulse arterial oxygen saturation of the index finger \< 95% because of potential deleterious effect on calf muscle StO2 from poor pulmonary gas exchange, and
failure to complete the baseline run-in phase within three weeks.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Oklahoma City?

Yes, this clinical trial (NCT05712395) has an active research site in Oklahoma City, OK that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Claudication Treatment Options in Oklahoma City, OK

If you're searching for claudication treatment options in Oklahoma City, OK, this clinical trial (NCT05712395) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced claudication specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all claudication clinical trials near you to find additional studies recruiting in your area.

More Peripheral Artery Disease Trials in Oklahoma City, OK

See all peripheral artery disease clinical trials recruiting in Oklahoma City — not just this study.

Browse Peripheral Artery Disease Trials in Oklahoma City →

Browse More Trials by Condition

Peripheral Artery Disease TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Oklahoma City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Oklahoma City, OK